Skip to navigation Skip to content

The Cancer Letter

Inside information on cancer research and drug development

  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
  • Current Issue
    • Past Issues
  • Events
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter

The Cancer Letter

Inside information on cancer research and drug development

  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
  • Current Issue
    • Past Issues
  • Events
BACK TO CONTRIBUTORS
Sarah Alwardt
Sarah Alwardt

Vice president of data, evidence and insights operations, McKesson Life Sciences

Latest Stories

ClinicalFree

Real-world data, evidence should be leveraged in clinical research to better include and ultimately treat larger patient populations

The growth of personalized medicine in oncology continues to fuel a shift from traditional chemotherapies to immunotherapy. Currently, there are more than 30 immunotherapies approved for use in the United States, with more than 2,300 immunotherapy clinical trials listed on ClinicalTrials.gov.
October 18, 2019
Vol.45 No.39
By Sarah Alwardt

Trending Stories

  • Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
  • Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
  • Biden commits to creating “ARPA-H” research body in visit to Ohio State
  • Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
  • The Cancer Letter gets a new website
  • Abecma receives FDA approval for multiple myeloma
ABOUT
ABOUT
About The Cancer Letter
Our Contributors
Editorial policies
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2021 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Twitter
LinkedIn
Facebook
Vimeo
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation
Login

Forgot your password?

Looking for IP Login?

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No